Fingerprint
Dive into the research topics of 'COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up
Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function
- NewYork-Presbyterian Hospital/Columbia University Irving Medical Center
- University of Insubria
- University of Texas Health Science Center at Houston
- Chinese PLA General Hospital
- Huazhong University of Science and Technology
- Leonard Davis Institute of Health Economics
- University of Vermont Medical Center
- University Montpellier
- Sotiria General Hospital Athens School of Medicine
- Harvard Medical School
- University Hospital of Verona
- Loyola University Medical Center
- Loyola University Chicago
- Clinical Trials Center
- University of Milan Bicocca
- Auckland City Hospital
- St Thomas' Hospital
- Hofstra University
- Eastern Michigan University
- McMaster University
- Ottawa Hospital Research Institute
- Vanderbilt University School of Medicine
- Imperial College London (Emeritus)
- Zena and Michael A. Wiener Cardiovascular Institute
- German Sport University Cologne
- Hospital Universitari Germans Trials I Pujol
- Yale School of Medicine
- Johannes Gutenberg University of Mainz
- University of Liverpool and Liverpool Heart and Chest Hospital
- Cardiovascular Research Foundation
- Universidad de Alcalá
- Institute of Clinical Pathology and Medical Research (ICPMR)
Research output: Contribution to journal › Review article › peer-review
2240
Citations
(Scopus)
32
Downloads
(Pure)